Sources

5 Total Sources

Roche Strikes $2.3 Billion Nurix Blood Cancer Drug Deal for Bexobrutideg

Left67%
Center33%
Reuters6h ago
Roche, Nurix Therapeutics Ink $2.3 Billion Blood Cancer Drug Deal for Bexobrutideg
Bloomberg6h ago
Roche to Pay Nurix Up to $2.3 Billion for Experimental Cancer Drug Rights - Bloomberg
StockTitan6h ago
Nurix, Roche ink bexobrutideg BTK deal up to $2.3B | NRIX Stock News
The Edge Malaysia1m ago
Roche to pay Nurix as much as US$2.3 bil in cancer drug deal
SWI swissinfo.ch in English4h ago
Roche joins Californian Nurix oncology programme - SWI swissinfo.ch